These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22179486)

  • 21. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
    Chiyomaru T; Enokida H; Tatarano S; Kawahara K; Uchida Y; Nishiyama K; Fujimura L; Kikkawa N; Seki N; Nakagawa M
    Br J Cancer; 2010 Mar; 102(5):883-91. PubMed ID: 20160723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-508-5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma.
    Wu SG; Huang YJ; Bao B; Wu LM; Dong J; Liu XH; Li ZH; Wang XY; Wang L; Chen BJ; Chen W
    Neoplasma; 2017; 64(1):40-47. PubMed ID: 27881003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5.
    Jiang Z; Zhang Y; Cao R; Li L; Zhong K; Chen Q; Xiao J
    Oncol Res; 2017 Aug; 25(7):1081-1087. PubMed ID: 28109084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
    Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
    Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
    Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
    Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Yu G; Jia Z; Dou Z
    Oncol Rep; 2017 Feb; 37(2):1123-1131. PubMed ID: 28000900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
    Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
    Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
    Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
    Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-338-3p inhibits the progression of bladder cancer through regulating ETS1 expression.
    Zhang L; Yan R; Zhang SN; Zhang HZ; Ruan XJ; Cao Z; Gu XZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1986-1995. PubMed ID: 30915741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression.
    Shang A; Yang M; Shen F; Wang J; Wei J; Wang W; Lu W; Wang C; Wang C
    Cell Physiol Biochem; 2017; 41(3):1179-1188. PubMed ID: 28268231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3.
    Sun S; Liu F; Xian S; Cai D
    Med Sci Monit; 2020 Jun; 26():e920331. PubMed ID: 32512576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
    Zhao X; Chen GQ; Cao GM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
    Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.
    Wang YY; Wu ZY; Wang GC; Liu K; Niu XB; Gu S; Meng JS
    Tumour Biol; 2016 Nov; 37(11):14553-14563. PubMed ID: 27631965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression.
    Wang W; Shen F; Wang C; Lu W; Wei J; Shang A; Wang C
    Tumour Biol; 2017 Jun; 39(6):1010428317698383. PubMed ID: 28618950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel microRNA targets based on microRNA signatures in bladder cancer.
    Ichimi T; Enokida H; Okuno Y; Kunimoto R; Chiyomaru T; Kawamoto K; Kawahara K; Toki K; Kawakami K; Nishiyama K; Tsujimoto G; Nakagawa M; Seki N
    Int J Cancer; 2009 Jul; 125(2):345-52. PubMed ID: 19378336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
    Yoshino H; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Nishiyama K; Nohata N; Seki N; Nakagawa M
    Br J Cancer; 2011 Mar; 104(5):808-18. PubMed ID: 21304530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.